Systemic Administration of Tumor Cells

Pre-Clinical Cancer Models: Orthotopic and Heterotopic



Systemic Administration of Tumor Cells

Pharmaseed offers a wide range of anti-cancer development models. These include the ability to examine the metastatic activity of cancer cells after they are administered into the host systematically. This enables Pharmaseed to fully evaluate the anti-metastatic potential of drug and treatment candidates.

 

Anti Metastatic Activity Model

Tumor Cells efficacy

Tumor Cells efficacy

Tumor cells (Lewis Lung Adenocarcinoma) were injected through tail vein, 21 days post inoculation mice were sacrificed and assessed for lungs metastases.

 

 

 

For more information on how we can help you
move your drug or device along the development pathway.
Contact Us